
Glenmark Pharmaceuticals Share Price
₹1,300.80 -48.15 (-3.57%)
22 Feb, 2025 21:22
Start SIP in
GLENMARK
Performance
- Low
- ₹1,290
- High
- ₹1,354
- 52 Week Low
- ₹883
- 52 Week High
- ₹1,831
- Open Price₹1,342
- Previous Close₹1,349
- Volume715,656
Investment Returns
- Over 1 Month -13.25%
- Over 3 Month -11.29%
- Over 6 Month -22.61%
- Over 1 Year + 44.44%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -208.8
- PEG Ratio
- -2.6
- Market Cap Cr
- 36,707
- P/B Ratio
- 4.3
- Average True Range
- 56.83
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- -32.52
- RSI
- 32.97
- MFI
- 25.21
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,300.80
-48.15
(-3.57%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹1,414.64
- 50 Day
- ₹1,474.08
- 100 Day
- ₹1,501.99
- 200 Day
- ₹1,427.73
Resistance and Support
1314.83
- R3 1,403.22
- R2 1,378.43
- R1 1,339.62
- S1 1,276.02
- S2 1,251.23
- S3 1,212.42
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,300 As on 22 February, 2025 | 21:08
The Market Cap of Glenmark Pharmaceuticals is ₹36707 Cr As on 22 February, 2025 | 21:08
The P/E ratio of Glenmark Pharmaceuticals is -208.8 As on 22 February, 2025 | 21:08
The PB ratio of Glenmark Pharmaceuticals is 4.3 As on 22 February, 2025 | 21:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.